Indegene & Microsoft Partner for Generative AI in Life Sciences
By Rediff Money Desk, New Delhi Jul 11, 2024 20:21
Indegene and Microsoft collaborate to help life sciences companies scale generative AI adoption, driving innovation and efficiency across the value chain.
New Delhi, Jul 11 (PTI) Healthcare tech firm Indegene on Thursday said it has tied up with Microsoft to empower global life sciences firms to scale up the adoption of Generative AI (GenAI) services, thereby driving faster innovation at scale.
The companies have committed to developing resources in medical and technology tools to co-innovate generative AI services and workflows across commercial, medical, regulatory, and clinical functions.
"GenAI presents a once-in-a-decade opportunity for life sciences companies to modernize business processes and reimagine the effectiveness and efficiency of their operations throughout the value chain.
"Using GenAI, we're closely working with many of our clients to solve specific business problems, with nearly 50 real-world use cases already in an advanced pilot stage," Indegene CTO Tarun Mathur said.
Microsoft India & South Asia Chief Operating Officer Alok Lall said Generative AI is profoundly shaping every industry, including life sciences, by offering unprecedented avenues for healthcare technology advancements.
"By seamlessly integrating Indegene's domain knowledge with Microsoft Azure OpenAI Service and Microsoft Copilot, we stand at the forefront of advancing generative AI within the life sciences sector," he added.
This collaborative effort empowers life sciences companies to fully harness AI's capabilities, fostering innovation and scalability within the industry, Lall said.
The companies have committed to developing resources in medical and technology tools to co-innovate generative AI services and workflows across commercial, medical, regulatory, and clinical functions.
"GenAI presents a once-in-a-decade opportunity for life sciences companies to modernize business processes and reimagine the effectiveness and efficiency of their operations throughout the value chain.
"Using GenAI, we're closely working with many of our clients to solve specific business problems, with nearly 50 real-world use cases already in an advanced pilot stage," Indegene CTO Tarun Mathur said.
Microsoft India & South Asia Chief Operating Officer Alok Lall said Generative AI is profoundly shaping every industry, including life sciences, by offering unprecedented avenues for healthcare technology advancements.
"By seamlessly integrating Indegene's domain knowledge with Microsoft Azure OpenAI Service and Microsoft Copilot, we stand at the forefront of advancing generative AI within the life sciences sector," he added.
This collaborative effort empowers life sciences companies to fully harness AI's capabilities, fostering innovation and scalability within the industry, Lall said.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- GTL Infrastructure
- 2.93 ( -4.87)
- 225649431
- IFL Enterprises
- 1.30 (+ 4.84)
- 67187874
- Vodafone Idea L
- 16.89 (+ 1.26)
- 55408189
- NCL Research
- 0.95 ( -4.04)
- 30640127
- Franklin Industries
- 3.73 (+ 3.32)
- 18100883
MORE NEWS
Auxilo Finserve Raises Rs 279 cr for Student...
Auxilo Finserve, an education-focused NBFC, secures Rs 279 crore funding from LeapFrog...
![Sugar Industry...](https://im.rediff.com/80-80/money/2017/jul/24sugar.jpg)
Sugar Industry Faces Issues Due to No MSP Hike:...
A federation official claims the sugar industry faces problems due to no MSP hike for...
![Sensex, Nifty Hit...](https://im.rediff.com/80-80/money/2021/may/14bse.jpg)
Sensex, Nifty Hit All-Time Highs: Market Update
Indian stock markets continue their upward trend, with Sensex and Nifty hitting new...